费诺纤维酸用于糖尿病视网膜病变
Sachiko Y Kataoka1, Noemi Lois2, Sumihiro Kawano3
1Department of Health informatics, Kyoto University School of Public Health, Kyoto, Japan.
对于大多数2型糖尿病患者来说,纤维酸可能对糖尿病视网膜病变 (DR) 的进展几乎没有影响. 然而,它可能会减缓现有的明显视网膜病变患者的DR进展,但会增加严重不良事件的风险.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病视网膜病变 (DR) 是全球导致失明的主要原因,给身体,心理和经济造成重大负担.
- 尽管糖尿病管理和新疗法取得了进展,但预防DR进展和危及视力的并发症仍然至关重要.
- 纤维酸正在研究其通过解决潜在的代谢和炎症途径来减轻DR的潜力.
结论:
- 目前的证据表明,纤维酸对T2D的整体DR进展的影响有限,但可能有利于明显视网膜病变患者.
- 严重不良事件的风险增加需要仔细考虑费诺纤维酸的使用.
- 需要进一步的研究,特别是在T1D人群中,专注于患者重要的结果和与其他DR治疗的比较有效性.
更多相关视频
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
相关概念视频
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Angle Closure Glaucoma: Treatment
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
